Table 4.
Brachial artery studies after supplementation. Data are means (± SE).
| Folic Acid Group (n = 8) |
Placebo Group (n = 5) |
|
|---|---|---|
| Heart rate (min) | 61 (6) | 54 (4) |
| Mean arterial pressure | ||
| Systolic (mmHg) | 102.5 (1.1 ) | 104.4 (3.0) |
| Diastolic (mmHg) | 65.3 (1.6) | 61.0 (4.0 ) |
| Temperature (°C) | 23.1 (.8) | 25.0 (.0) * |
| Humidity | 42.2 (2.5) | 46.4 (.9) |
| Baseline brachial artery diameter (mm) | 3.1 (.1 ) | 3.52 (.1) ** |
| Peak brachial artery diameter (mm) | 3.4 (.1) | 3.8 (.1) * |
| Flow-mediated dilation (%) | 10.0 (.9) | 6.65 (.7) * |
| Peak change in flow velocity (%) | 100.2 (10.0 ) | 110.4 (8.9) |
* and ** denote p < 0.05 and 0.01 respectivelyaccording to Exact Wilcoxon Rank-Sum Test.